An Exploratory Investigation of a Novel Skincare Regimen
1 other identifier
interventional
38
1 country
1
Brief Summary
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedAugust 26, 2022
August 1, 2022
3 months
August 24, 2022
August 24, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
4 weeks
Secondary Outcomes (1)
To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
4 weeks
Study Arms (1)
Aria Trio complete Facial System
EXPERIMENTALSkincare system targetting wrinkles, pore size, sun spots, and overall skin quality.
Interventions
Renew Serum, Brighten Serum, and Refine Serum.
Eligibility Criteria
You may qualify if:
- Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
- Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin)
- May experience hyperpigmentation and/or dark spots
- In good general health
- Willing to follow the study protocol skincare routine
- Willing and able to share feedback and take skin pictures via the technology portal
- Discontinue use of any alpha-hydroxy acids (AHAs) or over the counter exfoliating, polishing, or peeling topical skincare treatments 1 week before and for the duration of the study.
You may not qualify if:
- Anyone with a diagnosed skin condition on their face
- Use of prescription medication relevant to the skin
- Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments
- Use of oral acne treatment (e.g., Accutane)
- Severe chronic conditions, including oncological conditions or psychiatric disorders.
- Is pregnant, attempting pregnancy, or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Trophy Skinlead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Hill, PhD
Citruslabs
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2022
First Posted
August 26, 2022
Study Start
April 13, 2022
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
August 26, 2022
Record last verified: 2022-08